PATHOPHYSIOLOGICAL AND CLINICAL CORRELATIONS BETWEEN BRONCHIAL ASTHMA AND METABOLIC SYNDROME: A REVIEW
Introduction: Bronchial asthma (BA) and obesity represent significant challenges in contemporary medicine, with escalating prevalence in developed nations. This review aims to systematically analyze the pathophysiological and clinical interplay between bronchial asthma and metabolic syndrome, emphasizing their role in severe asthma development.
Search strategy: A thorough literature search was conducted up to May 10, 2024, using PubMed, Web of Science, and the Cochrane Central Register of Controlled Trials. The search spanned the past decade and employed predefined keywords based on Medical Subject Headings (MeSH). Inclusion criteria encompassed studies meeting evidence-based medicine standards and fundamental experimental research, published in English or Russian. Exclusion criteria included clinical case descriptions, non-evidence-based publications, and abstracts.
Results: This review synthesizes current insights into the mechanisms underlying the association between bronchial asthma and metabolic syndrome. A conventional perspective links asthma and the syndrome through mechanical effects of abdominal adipose tissue, impacting respiratory tract resistance and volumes. Furthermore, emphasis is placed on metabolic dysregulation's role in altering proinflammatory cytokine levels and adipose tissue hormone profiles. The review also introduces the concept of a metabolic phenotype in asthma, characterizing it as an independent variant within the spectrum of "bronchial asthma – metabolic syndrome - obesity." Pathogenetic relationships involving insulin resistance, hyperinsulinemia's epithelial effects on the respiratory tract, chronic inflammation, and respiratory hyperreactivity are highlighted.
Conclusions: The findings support a clinical and pathophysiological framework distinguishing a distinct "metabolic phenotype" in asthma patients. This phenotype underscores the interconnected pathogenesis involving insulin resistance, chronic inflammation, and heightened respiratory tract reactivity. Such insights contribute to advancing targeted therapeutic approaches for this subset of patients.
Keywords: metabolic syndrome, asthma, bronchospasm, obesity, insulin resistance.
Saule Yu. Maimysheva1, https://orcid.org/0000-0002-8010-1519
Lyudmila K. Karazhanova1, https://orcid.org/0000-0001-6664-3293
Andrey Yu. Orekhov1, https://orcid.org/0000-0001-7201-1399
Assel A. Chinybaeva2, https://orcid.org/0000-0002-2018-6186
Bolat A. Ashirov3, https://orcid.org/0000-0003-0242-9700
1. Aditi Shelke, Saurabh Shelke, Sourya Acharya, Samarth Shukla. Synergistic Epidemic or Syndemic: An Emerging Pattern of Human Diseases. Cureus. 2023. № 15 (11): e48286. doi: 10.7759/cureus.48286
2. Agrawal A. et al. Mechanistic understanding of the effect of obesity on asthma and allergy. Journal of allergy. 2013. Т. 2013. С.101-124.
3. Alemany M. The Metabolic Syndrome, a Human Disease. International Journal of Molecular Sciences. 2024. №25. 2251. https://doi.org/10.3390/ijms25042251
4. Baines K.J. et al. Impaired lung function is associated with systemic inflammation and macrophage activation. European Respiratory Journal. 2015. Т. 45. №.2. С. 557-559.
5. Baffi C. W. et al. Metabolic syndrome and the lung. Chest. 2016. Т. 149. №. 6. С. 1525-1534.
6. Bantulà M., Roca-Ferrer J., Arismendi E., Picado C. Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation. J. Clin. Med. 2021, 10, 169. https://doi.org/10.3390/jcm10020169
7. Bariaa A. Khalil, Narjes Saheb Sharif-Askari, Rabih Halwani. Role of inflammasome in severe, steroid-resistant asthma // Current Research in Immunology. 2023. №4. Р. 100061. doi.org/10.1016/j.crimmu.2023.100061
8. Bhatt N.A., Lazarus A. Obesity-related asthma in adults. Postgraduate medicine. 2016. Т. 128. №. 6. С. 563-566.
9. Brumpton B.M. et al. Metabolic syndrome and incidence of asthma in adults: the HUNT study. European Respiratory Journal. 2013. Т. 42. №. 6. С. 1495-1502
10. Forno E. et al. Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma. Journal of Allergy and Clinical Immunology. 2015. Т. 136. №. 2. С. 304-311.
11. Haixia Wang, Chenxiao Bai, Mo Yi, Yuanmin Jia, Yizhang Li, Di Jiang, Ou Chen. Metabolic Syndrome and Incident Asthma in Chinese Adults: An Open Cohort Study // Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020. №:13. P. 3411-3420. doi: 10.2147/DMSO.S274159.
12. Haneklaus M., O'neill L. NLRP3 at the interface of metabolism and inflammation. Immunological reviews. 2015. Т. 265. №. 1. С. 53-62.
13. Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nature immunology. 2015. Т.16. №.5. С. 448.
14. James W. Pinkerton, Richard Y. Kim, Alexandra C. Brown, Brittany E. Rae, Chantal Donovan, Jemma R. Mayall et al. Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma // American Academy of Allergy, Asthma & Immunology. 2021. № 149 (4). P.1270-1280 https://doi.org/10.1016/j.jaci.2021.10.003
15. Jay C. Horvat, Richard Y. Kim, Natasha Weaver, Christopher Augood, Alexandra C. Brown, Chantal Donovan et al. Characterization and inhibition of infammasome responses in severe and non-severe asthma // Respiratory Research. 2023. №24. Р. 303 https://doi.org/10.1186/s12931-023-02603-2
16. Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. Metabolic syndrome: definitions and controversies // BMC Med. 2011. №:9. eP. 48. https://doi.org/10.1186/1741-7015-9-48.
17. Kankaanranta H. et al. Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms. Mediators of Inflammation. 2016. Т. 2016. P e3690628
18. Leone N. et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. American journal of respiratory and critical care medicine. 2009. Т. 179. №. 6. С. 509-516.
19. Listyoko A.S., Okazaki R., Harada T., Inui G., Yamasaki A. Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications. Front. Allergy 2024. 5:1365801. doi: 10.3389/falgy.2024.1365801
20. Lugogo N.L., Bappanad D., Kraft M. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochimica et Biophysica Acta (BBA)-General Subjects. 2011. Т. 1810. №. 11. С. 1120-1126.
21. Mabalirajan U. et al. 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma. Scientific reports. 2013. Т. 3. С. 1540.
22. Mabalirajan U. et al. Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Scientific reports. 2013. Т. 3. С. 1349.
23. Marella Marassi, Gian Paolo Fadini. The cardio-renal-metabolic connection: a review of the evidence. Cardiovascular Diabetology. 2023. №22. P. 195 https://doi.org/10.1186/s12933-023-01937-x
24. Nie Z., Jacoby D. B., Fryer A. D. Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. American journal of respiratory cell and molecular biology. 2014. Т.51. №. 2. С. 251-261.
25. Nie Z., Jacoby D.B., Fryer A.D. Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. Amj. Respir Cell Mol Biol. 2014 51(2): 251-261
26. Oh I. H. et al. The association of normal range glycated hemoglobin with restrictive lung pattern in the general population. PloS one. 2015. Т.10. №.2. С. e0117725.
27. Perez M.K., Piedimonte G. Metabolic asthma: is there a link between obesity, diabetes, and asthma? Immunology and Allergy Clinics. 2014. Т.34. №.4. С. 777-784.
28. Peter W.F. Wilson, Ralph B. D’Agostino, Helen Parise, Lisa Sullivan, James B. Meigs Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus // Circulaion November 15, 2005 Vol 112, Issue 20
29. Rehman R. et al. TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury. International immunopharmacology. 2013. Т.15. №.3. С. 597-605.
30. Rosenstock J., Cefalu W.T., Hollander P.A., et al. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. Diabetes Technol Ther. 2009. 11(11):697–705.
31. Škrgat S., Harlander M., Jani´c M. Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes. Biomedicines 2024, 12, 173. https://doi.org/ 10.3390/biomedicines12010173
32. Savin I.A., Zenkova M.A., Sen’kova A.V. Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process. Int. J. Mol. Sci. 2023, 24, 16042. https://doi.org/10.3390/jms242216042
33. Schatz M. et al. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology. 2014. Т. 133. №. 6. С. 1549-1556.
34. Serafino-Agrusa L., Spatafora M., Scichilone N. Asthma and metabolic syndrome: current knowledge and future perspectives. World Journal of Clinical Cases: WJCC. 2015. Т. 3. №. 3. С. 285.
35. Shailesh H., Janahi I.A. Role of Obesity in Inflammation and Remodeling of Asthmatic Airway. Life 2022, 12, 948. https://doi.org/10.3390/life12070948
36. Singh S. et al. Insulin and the lung: connecting asthma and metabolic syndrome. Journal of allergy. 2013. Т. 2013. С.215-225.
37. Yurenko AV, Antonyuk MV, Mineeva EE, Novgorodtseva TP, Khodosova KK. Features of cytokine and adipokine regulation in asthma associated with obesity. Russian Open Medical Journal 2019; № 8: Р. e0203
38. Vernooy J.H.J. et al. Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulmonary pharmacology & therapeutics. 2013. Т. 26. №. 4. С. 464-472.
Number of Views: 126
Bibliography link
Maimysheva S.Yu., Karazhanova L.K., Orekhov A.Yu., Chinybaeva A.A., Ashirov B.A. Pathophysiological and Clinical Correlations between Bronchial Asthma and Metabolic Syndrome: A Review // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (3), pp. 136-143. doi 10.34689/SH.2024.26.3.016Related publications:
EMBOLIZATION OF THE UTERINE ARTERIES FOR LATE POSTPARTUM HEMORRHAGE DUE TO METROENDOMETRITIS: A CLINICAL CASE
DESCRIPTION OF A CLINICAL CASE OF GENERALIZED LYMPHADENOPATHY OF UNKNOWN ETIOLOGY
CLINICAL RELEVANCE OF KRAS MUTATION TESTING IN METASTATIC COLORECTAL USING DIFFERENT SEQUENCING PLATFORMS: A CASE REPORT
FIRST EXPERIENCE AND SUCCESSFUL SURGICAL TREATMENT OF LEFT KIDNEY CANCER WITH EXTENDED TUMOR VENOUS THROMBOSIS OF THE INFERIOR VENA CAVITY AND RIGHT ATRIUM [LEVEL IV] IN THE REPUBLIC OF KAZAKHSTAN
PROGNOSTIC SIGNIFICANCE OF GENETIC TUMOR MARKERS IN THYROID NEOPLASMS: LITERATURE REVIEW